Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target

Timmerman, Luika A., Holton, Thomas, Yuneva, Mariia, Louie, Raymond J., Padró, Mercè, Daemen, Anneleen, Hu, Min, Chan, Denise A., Ethier, Stephen P., van ‘t Veer, Laura J., Polyak, Kornelia, McCormick, Frank, Gray, Joe W.·2013·Cancer Cell
DOI 10.1016/j.ccr.2013.08.020

Cited by (575)

Items 401–500 of 575

  1. Reduced Expression of Annexin A6 Induces Metabolic Reprogramming That Favors Rapid Fatty Acid Oxidation in Triple-Negative Breast Cancer Cells
    Stephen D. Williams, Amos M. Sakwe · 2022 · Cancers
  2. A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options
    Daniela Criscuolo, Francesco Morra, Angela Celetti · 2022 · Exploration of Targeted Anti-tumor Therapy
  3. ASCT2 Regulates Fatty Acid Metabolism to Trigger Glutamine Addiction in Basal-like Breast Cancer
    Jia Wang, Qian Zhang, Huaizi Fu, Yi Han, Xue Li, Qianlin Zou, Shengtao Yuan, Li Sun · 2024 · Cancers
  4. Macropinocytosis mediates resistance to loss of glutamine transport in triple-negative breast cancer
    Kanu Wahi, Natasha Freidman, Qian Wang, Michelle Devadason, Lake‐Ee Quek, Angel Pang, Larissa Lloyd, Mark Larance, Fabio Zanini, Kate Harvey et al. · 2024 · The EMBO Journal
  5. β-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene
    Sakine Akar, Hamiyet Dönmez‐Altuntaş, Zühal Hamurcu · 2022 · Molecular Biology Reports
  6. Association between Alcohol Consumption and DNA Methylation in Blood: A Systematic Review of Observational Studies
    Dzevka Dragic, Sue-Ling Chang, Kaoutar Ennour‐Idrissi, Francine Durocher, Gianluca Severi, Caroline Diorio · 2022 · Epigenomics
  7. Artificial Diets Based on Selective Amino Acid Restriction versus Capecitabine in Mice with Metastatic Colon Cancer
    Julio José Jiménez‐Alonso, Emilio Guillén-Mancina, José Manuel Calderón‐Montaño, Víctor Jiménez-González, Patricia Díaz-Ortega, Estefanía Burgos‐Morón, Miguel López‐Lázaro · 2022 · Nutrients
  8. Artificial Diets with Selective Restriction of Amino Acids and Very Low Levels of Lipids Induce Anticancer Activity in Mice with Metastatic Triple-Negative Breast Cancer
    Emilio Guillén-Mancina, Julio José Jiménez‐Alonso, José Manuel Calderón‐Montaño, Víctor Jiménez-González, Patricia Díaz-Ortega, Estefanía Burgos‐Morón, Miguel López‐Lázaro · 2023 · Cancers
  9. Breast cancers as ecosystems: a metabolic perspective
    Flavia Martino, Mariadomenica Lupi, Enrico Giraudo, Letizia Lanzetti · 2023 · Cellular and Molecular Life Sciences
  10. Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma
    Enrica Balza, Patrizia Castellani, Paola Sánchez‐Moreno, Patrizia Piccioli, Iria Medraño-Fernández, Claudia Semino, Anna Rubartelli · 2017 · Oncotarget
  11. Altered Metabolism of Leukemic Cells: New Therapeutic Opportunity
    Júlia Starková, Ivana Heřmanová, Kateřina Hložková, Alzbeta Hararova, Jan Trka · 2017 · International review of cytology
  12. High-Throughput Screening Reveals New Glutaminase Inhibitor Molecules
    Renna Karoline Eloi Costa, Camila T. Rodrigues, Jean C. H. Campos, Luciana S. Paradela, Marília M. Dias, Bianca Novaes da Silva, Cyro von Zuben de Valega Negrão, Kaliandra de Almeida Gonçalves, Carolline Fernanda Rodrigues Ascenção, Douglas Adamóski et al. · 2021 · ACS Pharmacology & Translational Science
  13. Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas
    Joshua H. Choe, Simbarashe Mazambani, Tae Hoon Kim, Jung‐whan Kim · 2021 · Cells
  14. Targeting metabolism of breast cancer and its implications in T cell immunotherapy
    Jialuo Zou, Cunjun Mai, Zhiqin Lin, Jian Zhou, Guie Lai · 2024 · Frontiers in Immunology
  15. Free Salivary Amino Acid Profile in Breast Cancer: Clinicopathological and Molecular Biological Features
    Lyudmila Vladimirovna Bel’skaya, Elena A. Sarf, Denis V. Solomatin · 2024 · Current Issues in Molecular Biology
  16. NUAKs promote mTOR/c-Myc-induced glucose and glutamine reprogramming for cell growth and metastasis in breast cancer cells
    Acily Skadon Worral Wilfred Raj, Ravi Manoharan · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  17. KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage
    Zheqi Li, Guillermo Peluffo, Laura E. Stevens, Xintao Qiu, Marco Seehawer, Amatullah Tawawalla, Xiao-Yun Huang, Shawn B. Egri, Shaunak Raval, Maeve McFadden et al. · 2025 · Nature Genetics
  18. Chemical metabolomics for investigating the protective effectiveness of Acanthopanax senticosus Harms leaf against acute promyelocytic leukemia
    Yue Han, Aihua Zhang, Yingzhi Zhang, Hui Juan Sun, Xiangcai Meng, Xijun Wang · 2018 · RSC Advances
  19. Glutamine synthetase shields triple-negative breast cancer cells from ferroptosis in metastasis triggered by glutamine deprivation
    Zhaoting Yang, Xinyu Lian, Yuan Ming Luo, Qiao Ye, Guangjin Guo, Guoquan Liu · 2025 · Breast Cancer Research
  20. [The role of ferroptosis in chronic diseases].
    Junyi Chen, Yang Xiang, Xuexian Fang, Fudi Wang, Junxia Min · 2020 · PubMed Central
  21. Cell Death and Disease
    Ke Xu · 2022 · Biochemistry
  22. Targeting xCT with sulfasalazine suppresses triple-negative breast cancer growth via inducing autophagy and coordinating cell cycle and proliferation
    Yaping Long, Zizheng Xu, Jing Yu, Xiao Hu, Yu Xie, Xianxian Duan, Ning Li, Yan Yan, Yue Wang, Junfang Qin · 2024 · Anti-Cancer Drugs
  23. Glutathione peroxidase 4 (GPX4) and obesity interact to impact tumor progression and treatment response in triple negative breast cancer
    Emily N. Devericks, Bennett H. Brosnan, Alyssa N. Ho, Elaine M. Glenny, Hannah M. Malian, Dorothy Teegarden, Michael K. Wendt, Michael F. Coleman, Stephen David Hursting · 2025 · Cancer & Metabolism
  24. Nanomedicine strategies for disulfidptosis activation in SLC7A11-high tumors
    Zhanzheng Ye, Yinsha Yao, Yitianhe Xu, Jinyao Ye, Qing Yao, Longfa Kou, Ruijie Chen · 2025 · Colloids and Surfaces B Biointerfaces
  25. The Role of Amino Acids in the Diagnosis, Risk Assessment, and Treatment of Breast Cancer: A Review
    Lyudmila Vladimirovna Bel’skaya, Ivan A. Gundyrev, Denis V. Solomatin · 2023 · Current Issues in Molecular Biology
  26. Radiotracers for Nuclear Imaging of Reactive Oxygen Species: Advances Made So Far
    Lumei Huang, Zijing Li, Xianzhong Zhang · 2022 · Bioconjugate Chemistry
  27. Inhibiting STAT3 in a murine model of human breast cancer-induced bone pain delays the onset of nociception
    Katja Linher‐Melville, Manu Sharma, Peter Nakhla, Elena Kum, Robert G. Ungard, Ji E. Park, David A. Rosa, Patrick Thomas Gunning, Gurmit Singh · 2019 · Molecular Pain
  28. Cystine/cysteine metabolism regulates the progression and response to treatment of triple‑negative breast cancer (Review)
    Wanting Xiao, Chaoyang Xu · 2024 · Oncology Letters
  29. Metabolic interplay between exogenous cystine and glutamine dependence in triple-negative breast cancer
    Ziqian Ge, Martina Wallace, Rory Turner, Maureen Yin, Mary F. Rooney, Richard K. Porter · 2025 · Cell Death Discovery
  30. Effect of glutaminase inhibition on cancer-induced bone pain
    Jennifer Fazzari, Gurmit Singh · 2019 · Breast Cancer Targets and Therapy
  31. Overview of Glutamine Dependency and Metabolic Rescue Protocols
    Shuo Qie, Dan He, Nianli Sang · 2019 · Methods in molecular biology
  32. Effects of antiseizure medications on placental cells: Focus on heterodimeric placental carriers
    Nino Tetro, Roa’a Hamed, Erez Berman, Sara Eyal · 2021 · Epilepsy Research
  33. Glutamate promotes triple-negative breast cancer development through IRE1α/XBP1-mediated macrophage polarization: mechanism insights and therapy
    Hao Wang, Jifeng Sun, Zhansheng Jiang, Zhongsheng Tong, Chen Wang · 2025 · Discover Oncology
  34. Apoptotic neutrophil membrane-modified nanoparticles promote wound healing by enhancing efferocytotic capacity of dendritic cells
    Kai Ye, Yan He, Danfeng Jian, Zhengtai Chen, Hanxiao Sun, Yufan Zhang, Yuexue Mai, Xinran Cao, Jindan Wu, Zhengwei Mao et al. · 2025 · Journal of Controlled Release
  35. Ferroptosis in Autoimmune Diseases: Research Advances and Therapeutic Strategies
    Ziman He, Bo Liu, Zuquan Xian, Aimin Gong, Xiaokang Jia · 2025 · International Journal of Molecular Sciences
  36. Causal effects of circulating glutamine on colitis, IBD, and digestive system cancers: a Mendelian randomisation study
    Yang Xie, Yonghui Wu, Qing Tao, Youxiang Chen, Chunyan Zeng · 2024 · Journal of Cancer
  37. Transmembrane Amino Acid Transporters in Shaping the Metabolic Profile of Breast Cancer Cell Lines: The Focus on Molecular Biological Subtype
    Elena I. Dyachenko, Lyudmila Vladimirovna Bel’skaya · 2024 · Current Issues in Molecular Biology
  38. The mitochondrial enzyme FAHD1 regulates complex II activity in breast cancer cells and is indispensable for basal BT ‐20 cells in vitro
    Max Holzknecht, Lena Guerrero‐Navarro, Michèle Petit, Eva Albertini, Elisabeth Damisch, Anna Simonini, Fernando Carlos Schmitt, Walther Parson, Heidi Fiegl, Alexander K. H. Weiss et al. · 2022 · FEBS Letters
  39. Structural investigation of human cystine/glutamate antiporter system xc − (Sxc −) using homology modeling and molecular dynamics
    Hang Dieu Tran, Hung Minh Huynh, Pauline Beckers, N. Desmet, M. Lamrani, A. Massie, E. Hermans, K. Vanommeslaeghe · 2022 · Frontiers in Molecular Biosciences
  40. Fold change based approach for identification of significant network markers in breast, lung and prostate cancer
    Richa Makhijani, Shital Raut, Hemant J. Purohit · 2018 · IET Systems Biology
  41. Repurposing Drugs as Novel Triple-negative Breast Cancer Therapeutics
    Amiya Das, Pallavi Agarwal, Gaurav Kumar Jain, Geeta Aggarwal, Viney Lather, Deepti Pandita · 2021 · Anti-Cancer Agents in Medicinal Chemistry
  42. The Effect of Chirality on the Application of 5-[18F]Fluoro-Aminosuberic Acid ([18F]FASu) for Oxidative Stress Imaging
    Milena Čolović, Hua Yang, Helen Merkens, Nadine Colpo, François Bénard, Paul C. Schaffer · 2019 · Molecular Imaging and Biology
  43. Comparative Evaluation of [18F]5-Fluoroaminosuberic Acid and (4S)-4-3-[18F]fluoropropyl)-l-Glutamate as System –Targeting Radiopharmaceuticals
    Milena Čolović, Hua Yang, Lily Southcott, Helen Merkens, Nadine Colpo, François Bénard, Paul C. Schaffer · 2023 · Journal of Nuclear Medicine
  44. Delivery-Graded Programmable Micelles Achieve Enhanced Tumor Starvation through Combined Glutamine Deprivation and Angiogenesis Inhibition
    Xuan Wei, Jiamin Cheng, Meijuan Geng, Siyu Chen, Liyang Gong, Siyu Meng, Keying Chen, Ziyan Wang, Yuan Zhang, Kaiyong Cai et al. · 2025 · Research
  45. The implication of aberrant NRF2 activation in management of female cancers
    Mankgopo Magdeline Kgatle, Saidon Mbambara, Olalekan Olatunde Fadebi, Joseph Kabunda, Chimbabantu Alexis Kaoma, Thobeka Dlangalala, Siphesihle Robin Nxele, Ndimo Modipane, Thato Serite, Kgomotso M. G. Mokoala et al. · 2025 · Frontiers in Oncology
  46. Translational paradigm of advanced nanoscale strategies for triple negative breast cancer (TNBC): mechanistic insights, metastatic pathways, and emerging theragnosis
    Soumya Sonalisha, Apoorv Kirti, S.P. Asima, Richeek Parashar, Srijeeta Pal, Debidatta Barik, Shaikh Sheeran Naser, Eliana B. Souto, Suresh K. Verma · 2026 · Materials Advances
  47. Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer
    Yan Yang, Jie Du, Yunfei Huang, Wei He, L.-Z. Liu, Dan Li, Rui Chen · 2023 · Oncology Letters
  48. Novel Withanolides from Tubocapsicum anomalum Suppress Triple-Negative Breast Cancer by Triggering Apoptosis and p53-ASCT2-SLC7A11-Mediated Ferroptosis
    Lili Huang, Yingying Wei, Maowei Ni, Hongtao Hu, Luyi Xi, Chen Wang, Zhihui Zhu, Bo Yang, Huajun Zhao · 2024 · Molecules
  49. Interactions between ferroptosis and tumour development mechanisms: Implications for gynaecological cancer therapy (Review)
    Peng Wu, Jianlin Chen, Hui Li, Haiyuan Lu, Yukun Li, Juan Zhang · 2024 · Oncology Reports
  50. Metabolomics as a tool for understanding and treating triple-negative breast cancer
    Gyas Khan, Md Sadique Hussain, Sarfaraz Ahmad, Nawazish Alam, Sajid Ali, Prawez Alam · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  51. Exploiting the metabolic dependencies of the broad amino acid transporter SLC6A14
    Francesca R. Dejure, Joachim Butzer, Ralph K. Lindemann, Balca R. Mardin · 2020 · Oncotarget
  52. Cysteine Metabolism in Cancer Progression and Therapy Resistance
    Dawn Sijin Nin, Shabana Binte Idres, Lih‐Wen Deng · 2021 · Springer eBooks
  53. Mechanism and application of nonessential amino acid deprivation associated with tumor therapy
    Shiqi Nong, Yuran Qian, Tingyue Zhang, Xueyan Zhou, Yuhao Wei, Xiaomeng Yin, Xuelei Ma · 2022 · MedComm – Future Medicine
  54. Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models
    Giuseppina Barutello, Antonino Di Lorenzo, Alessandro Gasparetto, Chiara Galiazzi, Elisabetta Bolli, Laura Conti, Federica Cavallo · 2022 · Biomedicines
  55. Extracellular matrix detached cancer cells resist oxidative stress by increasing histone demethylase KDM6 activity
    Mohamed A. Alfaleh, Mohammed Razeeth Shait Mohammed, Anwar M. Hashem, Turki S. Abujamel, Nabil A. Alhakamy, Mohammad Imran Khan · 2023 · Saudi Journal of Biological Sciences
  56. Salidroside can protect against ferroptosis in cardiomyocytes and may be related to the regulation of GGT1
    Tianhang Feng, Jing Shi, Jinghua Zhao, Qin Zhao, Tao Wang, Sha Wan, Fan Chen, Sijia Wang, Chunyou Lai, Yutong Yao · 2025 · Frontiers in Pharmacology
  57. Mitochondrial ROS inhibition prevents doxorubicin-induced breast cancer cell migration and invasion
    Tânia Capelôa, Justine A. Van de Velde, Erica Pranzini, Luigi Ippolito, Luca X. Zampieri, Morgane Tardy, Thibaut Vazeille, Alan Provito, Giovanna Carrà, Alfonso Scalera et al. · 2025 · iScience
  58. Breaking the vicious cycle: Multifunctional nanomaterials targeting Tumor metabolic reprogramming to overcome T cell exhaustion and bone repair failure in bone tumors
    Shijin Guo, Ziyi Yan, Yuling Huang, Xueneng Hu, Huaiyuan Zhang, Yu Wang, Tinglin Zhang, Huifen Qiang, Minghao Xue, Jie Gao et al. · 2025 · Materials Today Bio
  59. SLC7A11 as a molecular nexus of prognosis, resistance, and therapeutic roadmap in cancer: A systematic review and meta-analysis
    Arpana Sharma, Yogesh Srivastava, Sanway Prasad, Sushmita Ghosh, R Suresh Kumar, Alok Chandra Bharti, Rana Pratap Singh, Vilas D. Nasare · 2025 · International Journal of Biological Macromolecules
  60. SLC7A11-HSPB1 axis: A novel mechanism for hepatocellular carcinoma progression and ferroptosis regulation
    Yan An, Weilong Liu, Yuliang Deng, Wanqiu Huang, Jian Huang · 2025 · Biomedical Journal
  61. Transcriptome Profiling of Cisplatin Resistance in Triple-negative Breast Cancer: New Insight into the Role of PI3k/Akt Pathway
    Maryam Memar, Touraj Farazmandfar, Amir Sabbaghian, Majid Shahbazi, Masoud Golalipour · 2022 · Current Molecular Medicine
  62. Starving cancer cells to enhances DNA damage and immunotherapy response
    Aashirwad Shahi, Dawit Kidane · 2024 · Oncotarget
  63. Sensitivity of triple negative breast cancer cells to ATM-dependent ferroptosis induced by sodium selenite
    Mengchen Xu, Xu Gao, Yue Lu, Jinyu Li, Xiaoya Feng, Dejun Huang, Hui Cai, Yongmei Qi · 2024 · Experimental Cell Research
  64. The Novel Anti-tumor Therapy Targeting the “Functional” Cancer Stem Cell Markers
    Hideyuki Saya · 2014 · Clinical and Experimental Pharmacology
  65. Extrinsic hyaluronic acid induction differentially modulates intracellular glutamine metabolism in breast cancer stem cells
    Heena Jariyal, Harsh Thakkar, A Suresh Kumar, Medha Bhattacharyya, Ravi P. Shah, Akshay Srivastava · 2022 · International Journal of Biological Macromolecules
  66. Uncovering the modified immunopeptidome reveals insights into principles of PTM-driven antigenicity
    Assaf Kacen, Aaron Javitt, Matthias P. Kramer, David Morgenstern, Tomer Tsaban, Adam Solomon, Guo Ci Teo, Felipe da Veiga Leprevost, Eilon Barnea, Fengchao Yu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Oncogenic role of the SLC7A13-SLC3A1 cystine transporter in human luminal breast cancer and its cryo-EM structure
    Jing Dong, Tianhao Shi, Bingbiao Lin, Xuetong Liu, Waner Wei, Zichi Geng, Ming-Cheng Liu, Renhong Yan, Jin‐Tang Dong · 2025 · Protein & Cell
  68. Overcoming Therapeutic Resistance in Triple-Negative Breast Cancer: Targeting the Undrugged Kinome
    Chang Hoon Lee, Tuan Minh Nguyen, Yongook Lee, Seoung Gyu Choi, Phương Ngân Nguyễn, Jung Ho Park, Mi Kyung Park · 2025 · International Journal of Molecular Sciences
  69. Therapeutic implication of oxidative stress-induced growth inhibitor 1 (OSGIN1) in cancer
    Dong Joon Kim, Yong Weon Yi, Zigang Dong, Yeon‐Sun Seong · 2025 · Oncogene
  70. Neddylation: from regulatory mechanisms to clinical implications in cancer
    Ming Zhang, Qiu Peng, Yunxiang Feng, Tao Yang, Wei Yao, Zhengdong Deng, Jianming Wang · 2025 · Journal of Advanced Research
  71. Ferroptosis: Physiological and pathophysiological aspects
    Marcus Conrad, Milene Costa da Silva · 2019 · Elsevier eBooks
  72. Molecular mechanisms of cell death
    Muthu Kumaraswamy Shanmugam, Gautam Sethi · 2021 · Elsevier eBooks
  73. Retracted: Methionine‐CBS axis promotes intracellular ROS levels by reprogramming serine metabolism
    Jingyun Chen, Xiangyan Cui, Ning Fang, Yu Wu, Shujian Yu, Dong Xiao · 2023 · The FASEB Journal · Retracted
  74. Genetic estimation of correlations between circulating glutamine and cancer.
    Kai Zhang, Hongjin Liang · 2023 · PubMed Central
  75. CAV1 inhibits Xc- system through IFNGR1 to promote ferroptosis to inhibit stemness and improves anti-PD-1 efficacy in breast cancer
    Wenhong Liu, Guanghua Luo · 2024 · Translational Oncology
  76. Protonation constants of endo- and exogenous L-amino acids and their derivatives in aqueous and mixed solution: Unraveling molecular secrets
    Marek Pająk, Jakub Fichna, Magdalena Woźniczka · 2024 · Quarterly Reviews of Biophysics
  77. The role of SLC7A11 in arsenite-induced oncogenic phenotypes of human bronchial epithelial cells: A metabolic perspective
    Xin Hua Fang, Yihui Ruan, Xianhang Yin, Junyi Wang, Chen Chen, Yuxin Hu, Huihui Wang, Jingbo Pi, Yuanyuan Xu · 2025 · Environmental Pollution
  78. Intracellular glutathione levels affect the outcomes of verteporfin-mediated photodynamic therapy in esophageal cancer cells
    Mirai Edano, Tsutomu Kanda, Ryohei Tarumoto, Wataru Hamamoto, Takashi Hasegawa, Yukari Mae, Takumi Onoyama, Tomoaki Takata, Takaaki Sugihara, Hajime Isomoto · 2022 · Photodiagnosis and Photodynamic Therapy
  79. Phosphoribosyl pyrophosphate amidotransferase: Novel biomarker and therapeutic target for nasopharyngeal carcinoma
    Yuki Kitagawa, Satoru Kondo, Masaki Fukuyo, Kousho Wakae, Hirotomo Dochi, Harue Mizokami, Shigetaka Komura, Eiji Kobayashi, Nobuyuki Hirai, Takayoshi Ueno et al. · 2024 · Cancer Science
  80. Non-invasive Use of Positron Emission Tomography to Monitor Diethyl maleate and Radiation-Induced Changes in System xC− Activity in Breast Cancer
    Milena Čolović, Hua Yang, Helen Merkens, Nadine Colpo, François Bénard, Paul C. Schaffer · 2019 · Molecular Imaging and Biology
  81. Global Trends in Research of Amino Acid Metabolism in T Lymphocytes in Recent 15 Years: A Bibliometric Analysis
    蔡柳新, Yinan Yu, Yinan Yu, Yuting Meng, Kefan Qiu, Guozhong Niu, Chao Wei, TianWen Chen, Yan Wu, Xiujun Cai et al. · 2025 · Journal of Immunology Research
  82. Reprogramming of amino acid metabolism in breast cancer
    Meijin Wang, Yunlu Zhang, Zhenhua Li, Li Fu · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  83. Fucosylated N-Glycan Landscape of Triple-Negative Breast Cancer
    Danielle A. Scott, Souvik Seal, Laura Spruill, Jaclyn Dunne, Graham A. Colditz, Anand S. Mehta, Richard R. Drake, Marvella Elizabeth Ford, Peggi M. Angel · 2025 · Molecular Cancer Research
  84. An engineered cysteine sensor optimized for high-throughput screening identifies regulators of intracellular thiol levels.
    Rachel P. M. Abrams, R. Donahue, Jessica Ma, Ying Mao, Morgan E. Diolaiti, Alan Ashworth · 2025 · Cell Chemical Biology
  85. Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer
    Sabrina Guo, Christina Addison · 2026 · Current Oncology
  86. Fasting-mimicking diet: a metabolic approach for the treatment of breast cancer
    Francesca Ligorio, Leonardo Provenzano, Claudio Vernieri · 2023 · Current Opinion in Oncology
  87. Integrated stress response-upregulated mitochondrial SLC1A5var enhances glucose dependency in human breast cancer cells in vitro
    Sheng‐Fan Wang, Yu-Chieh Ho, Chian‐Ying Chou, Yuh‐Lih Chang, Hsin‐Chen Lee, Ling‐Ming Tseng · 2024 · The International Journal of Biochemistry & Cell Biology
  88. Repurposing Asparaginase Therapy to Target Cisplatin‐Resistant Cancer Cells
    J.S. Wang, Nasim Pouryaghoub, Robert Strauss, Jiří Bártek, Si Min Zhang, Sean G. Rudd · 2025 · Fundamental and Clinical Pharmacology
  89. Clinicopathological analysis of GLUT-1, GLS1, and GLS2 expression in breast cancer tissues from Jordanian patients
    Haneen A. Basheer, Ahlam Zaid Alkilani, Samir M. Al Bashir, Maram A. Alhusban, Lina Elsalem, Samah O. Al-Omari, Qosay Mahmoud Sharqiah, Kamyar Afarinkia · 2025 · Scientific Reports
  90. Kanglaite alleviates lung squamous cell carcinoma through ferroptosis
    Meiling Jiang, Li Liu, Zilin Wang, Xue Yang, Zhiyong Lin, Runqiu Jiang, Cun‐Jin Zhang, Weiyan Wang · 2024 · International Immunopharmacology
  91. Metabolic Pathways of Eukaryotes and Connection to Cell Mechanics
    Claudia Tanja Mierke · 2020 · Biological and medical physics, biomedical engineering
  92. Leukemia Cells Resistant to Glutamine Deprivation Express Glutamine Synthetase Protein
    Burcu Yücel, Saniye Ada · 2021 · Turkish Journal of Hematology
  93. Role of glutamine metabolism in tuberculosis pathogenesis: a mini review
    Sadiya Parveen, William R. Bishai · 2024 · Frontiers in Tuberculosis
  94. xCT as a Predictor for Survival in a Population‐Based Cohort of Head and Neck Squamous Cell Carcinoma
    Linda Nissi, Sanni Tuominen, Johannes Routila, Teemu Huusko, Petra Ketonen, Maria Sundvall, Ilmo V.V. Leivo, Heikki Irjala, Heikki R. I. Minn, Tove J. Grönroos et al. · 2024 · Cancer Medicine
  95. SLC7A11 and the glutathione pathway as novel prognostic markers in resectable pancreatic ductal adenocarcinoma: A metabolomics study of clinical specimens
    Hiroki Ohya, Kentaro Miyake, Hironori Fukuoka, Masanori Oshi, Atsushi Ishibe, Koji Narita, Ken Kasahara, Itaru Endo · 2024 · Pancreatology
  96. CRL3 E3 ligase regulates glutamine and cystine metabolisms
    Qiyin Zhou, Zhijian Li, Yi Sun · 2024 · Protein & Cell
  97. Clinicopathological characteristics of invasive stratified mucinous carcinoma of the cervix and the expression and clinical significance of SLC7A11, SLC3A2 and PD-L1
    Changyu Lu, Wei Zhu, Xiahui Han, Xiuzhen Du, Hui Zhang, Qin Yao, Ting Liu, Ce Zhang · 2024 · Frontiers in Oncology
  98. Hypoxia Suppresses Cysteine Deprivation-induced Cell Death Via ATF4 Regulation in MDA-MB-231 Breast Cancer Cells
    Sung‐Eun Hong, Miri Kim, Se‐Kyeong Jang, Min-Ki Seong, Hyun‐Ah Kim, Woo Chul Noh, Hyeon‐Ok Jin, In‐Chul Park · 2020 · Anticancer Research
  99. The effect of different storage times on the oxygen-carrying capacity of the exosomes of red blood cells
    Li‐Shuang Duan, Yang Liu, Zhen-Zhou Li, Huan Wang, Xiaofang Zhou, Xiaoxiao Wang, Zi-Wei Zhang, Yi-Qun Kang, Yongjun Su, Jian-Rong Guo · 2021 · Advances in Clinical and Experimental Medicine
  100. Establishment of a new canine inflammatory mammary carcinoma cell line and analysis of its cystine-glutamate transporter subunit expression
    Harumichi Itoh, Ryo Naruse, Kenji Tani, Hiroshi Sunahara, Yuki Nemoto, Munekazu NAKAICHI, Toshie Iseri, Hiro Horikirizono, Kazuhito ITAMOTO · 2022 · Journal of Veterinary Research